Mydecine Innovations Group Inc MYCOD
$0.10
Last Updated: Nov 06, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
MYCOD Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Mydecine Innovations Group Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Mydecine Innovations Group Inc. Stock Analysis MYCOD
United States Health Care Nano Cap Mydecine Innovations Group Inc is a CA-based company operating in Pharmaceuticals industry. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2014-08-18. Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The firm is engaged in developing the next generation of medications and therapies to address mental health disorders, such as nicotine addiction and post traumatic stress disorder (PTSD). The firm conducts research and development on novel second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The firm has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The firm is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). The company uses advanced artificial intelligence (AI) and machine learning to design and screen drugs of interest. Its subsidiaries include Mydecine Group (1220611 BC Ltd) and NeuroPharm Inc.
Mydecine Innovations Group Inc (MYCOD) Chart
Financial Metrics & Statements of Mydecine Innovations Group Inc (MYCOD)
FAQ's for Mydecine Innovations Group Inc (MYCOD)
- As of August 2026, Mydecine Innovations Group Inc MYCOD is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Mydecine Innovations Group Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Mydecine Innovations Group Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Mydecine Innovations Group Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Mydecine Innovations Group Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Mydecine Innovations Group Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Mydecine Innovations Group Inc (MYCOD)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
